Danaos Corporation vs Novo Nordisk A/S — how do they compare? Danaos Corporation trades at $135.01 (market cap $2.46B), while Novo Nordisk A/S trades at $45.9 (market cap $207.85B). The key difference: Novo Nordisk A/S is far larger — about 84.5× Danaos Corporation's market cap, and Novo Nordisk A/S pays the higher dividend (3.81%). Which is the better fit depends on your goals.
| DAC | NVO | |
|---|---|---|
Market Cap | $2.46B | $207.85B |
Sector | Technology | Health |
52-Week High | $143.15 | $63.98 |
52-Week Low | $84.05 | $35.29 |
Enterprise Value | $2.44B | $222.55B |
Dividend Yield | 2.67% | 3.81% |
Trailing returns across standard periods
Latest headlines on both assets
Danaos is a leading international owner of containerships, providing seaborne transportation services globally. It charters its fleet of vessels to major shipping lines across Asia, Europe, and the Americas.
Read more on DAC →With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →